by Riley Nolan | Aug 22, 2022 | Featured, Thinking Out Loud -Blog
After almost three year of virtual meetings, EpiVax is back on the road in earnest this fall! We are so excited to reconnect in person with our clients, partners and friends around the globe. And this fall we have an ambitious travel schedule! Check out the list...
by Riley Nolan | Aug 1, 2022 | Featured, Thinking Out Loud -Blog
Defining Fearless Science If you’ve been reading “Thinking out Loud” since I started writing this blog, you know that we espouse the concept of Fearless Science. Meaning, we report what we see, even if it doesn’t fit the dogma. Take COVID...
by Riley Nolan | Jul 4, 2022 | Events, Featured
The EpiVax team had a great time in Tokyo hosting the Westin Immunogenicity Seminar! Please see pictures from the event below. Stay tuned for dates/details for 2023! The EpiVax team is pleased to share a new date for the 14th Annual Westin Tokyo Seminar, Friday...
by Riley Nolan | Mar 24, 2022 | Featured, Thinking Out Loud -Blog, Uncategorized
Gene Therapies – time to think about Immunogenicity I just returned from the Gene Therapies for Rare Disorders meeting in Boston… and wow, what an exciting time for these therapies! Here’s a good overview of AAV therapies currently approved and in clinical trials for...
by Riley Nolan | Nov 4, 2021 | Featured, News
PROVIDENCE, RI, November 4, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce an important commercial licensing agreement with Maruho Co., Ltd. (“Maruho”) for EpiVax’s patented Tregitope technology. This marks an exciting step for Maruho and...